The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states

被引:89
作者
Giraldi, Francesca Pecori
Pivonello, Rosario
Ambrogio, Alberto Giacinto
De Martino, Maria Cristina
De Martin, Martina
Scacchi, Massimo
Colao, Annamaria
Toja, Paola Maria
Lombardi, Gaetano
Cavagnini, Francesco
机构
[1] Univ Milan, Osped San Luca, IRCCS, Ist Auxol Italiano,Dept Endocrinol, I-20149 Milan, Italy
[2] Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Naples, Italy
关键词
D O I
10.1111/j.1365-2265.2006.02717.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Cushing's syndrome (CS), when fully expressed, is easily diagnosed. Mild cases, however, may require careful distinction from pseudo-Cushing's states as may occur in depression, alcoholism, polycystic ovary disease and visceral obesity. The aim of the present study is a reappraisal of the diagnostic accuracy of the two tests most commonly used to differentiate CS from pseudo-Cushing's: corticotropin-releasing hormone (CRH) stimulation after low dose dexamethasone administration and desmopressin stimulation. Design The study population comprised 32 patients with CS and 23 with pseudo-Cushing's evaluated retrospectively. Methods Urinary free cortisol (UFC), serum cortisol at midnight and after low dose dexamethasone (1 mg overnight and 2 mg over two days) were measured. Further, patients were tested with dexamethasone + CRH and desmopressin and the diagnostic performances of the two tests were compared in the entire series as well as in patients with mild hypercortisolism only (i.e. UFC < 690 nmol/24 h). Results As expected, measurement of UFC, assessment of cortisol rhythmicity and inhibition after 1 mg/2 mg dexamethasone failed to clearly classify patients with pseudo-Cushing's. Administration of CRH following 2-mg dexamethasone achieved 100% sensitivity but 62.5% specificity. Conversely, desmopressin testing correctly classified all but two patients with pseudo-Cushing's (90% specificity) with 81.5% sensitivity. Diagnostic accuracy was comparable in the subgroup with mild hypercortisolism (21 CS, all 23 pseudo-Cushing's patients). Desmopressin offered an incremental diagnostic effectiveness of 35.8/million inhabitants compared with dexamethasone + CRH as a second-line test. Conclusions Neither of the two tests guarantees absolute diagnostic accuracy. The specificity of dexamethasone + CRH is less brilliant than previously reported and appears to be inferior to desmopressin stimulation. The greatest diagnostic effectiveness results from the low-dose dexamethasone test combined with the desmopressin test. Skilful use of dynamic testing and balanced clinical judgement are necessary to distinguish between Cushing's syndrome and pseudo-Cushing's.
引用
收藏
页码:251 / 257
页数:7
相关论文
共 26 条
[21]   ADVANCES IN THE DIAGNOSIS AND TREATMENT OF CUSHINGS-SYNDROME [J].
TSIGOS, C ;
PAPANICOLAOU, DA ;
CHROUSOS, GP .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1995, 9 (02) :315-336
[22]   On the mechanism of alcohol-induced pseudo-Cushing's syndrome [J].
Veldman, RG ;
Meinders, AE .
ENDOCRINE REVIEWS, 1996, 17 (03) :262-268
[23]   Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - Recommendations for a protocol for biochemistry laboratories [J].
Wood, PJ ;
Barth, JH ;
Freedman, DB ;
Perry, L ;
Sheridan, B .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :222-229
[24]  
YANOVSKI JA, 1993, JAMA-J AM MED ASSOC, V269, P2232, DOI 10.1001/jama.269.17.2232
[25]   THE LIMITED ABILITY OF INFERIOR PETROSAL SINUS SAMPLING WITH CORTICOTROPIN-RELEASING HORMONE TO DISTINGUISH CUSHINGS-DISEASE FROM PSEUDO-CUSHING STATES OR NORMAL PHYSIOLOGY [J].
YANOVSKI, JA ;
CUTLER, GB ;
DOPPMAN, JL ;
MILLER, DL ;
CHROUSOS, GP ;
OLDFIELD, EH ;
NIEMAN, LK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :503-509
[26]  
YANOVSKI JA, 1995, 77 ANN M END SOC WAS